Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Rekovelle in Oocyte Donors
NCT04778358Phase 2Completed
- Sponsor
- International Vaccine Institute
- Start
- Sep 2021
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human follicle stimulating hormone in female infertility, sponsored by International Vaccine Institute. Started Sep 2021; status: completed.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT04778358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04778358.